Investment
Features
FeesSafety
Academy
More
Pluang+

DeFi Development adds 55,491 SOL and launches $300M preferred stock ATM program.

Protocol Fundamentals
14 Sep 2026
Coincu
View Source
Neutral
DeFi Development adds 55,491 SOL and launches $300M preferred stock ATM program.

DeFi Development increased its Solana holdings by 55,491 SOL and established a $300 million at-the-market (ATM) program for its CHAD preferred stock. The ATM program allows the company to sell shares incrementally in the market but has not yet raised any funds. The announcement does not confirm if the SOL addition was funded by the ATM program or provide details on the terms of the preferred stock. Further verification is needed on transaction dates, acquisition costs, and total holdings.

DeFi Development's recent addition of 55,491 SOL and establishment of a $300 million ATM program for CHAD preferred stock provide context for readers. For those following the broader cryptocurrency market on Pluang, as of Sep 14, 2026 20:03 WIB, 30 of 50 major cryptocurrencies rose while 19 fell. Notable movers include AVAX with a price of Rp131.688 and a 1-day change of +2.72%, ONE at Rp12 with a -2.71% change, and MANA at Rp1.326 down by -2.43%, with Pluang order activity showing varying buy and sell ratios.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App